The Motley Fool

4 investment stories you missed in the ASX200 this week

The S&P/ASX 200 (Index: ^AXJO) (ASX: XJO) was eventful this week. Here are four big stories you may have missed that affected the ASX 200 index:

Commonwealth Bank of Australia (ASX: CBA) delays wealth demerger

Commonwealth Bank had been on track to demerge its wealth management and mortgage broking businesses.

Whilst the bank said it is prioritising the implementation of the Royal Commission recommendations, refunding customers and remediating past issues, CBA has suspended its demerging process in order to support the focus on those priorities.

Kogan.Com Ltd (ASX: KGN) takes on Amazon

Aussie online retail Kogan.Com has launched Kogan Marketplace, a place where over 100,000 products are sold from a wide array of third party brands including Microsoft, Breville Group Ltd (ASX: BRG), Lego, Fisher-Price, Paw Patrol, SodaStream, Gillette, Gucci, and Philips.

This news sent the Kogan.Com share price higher 4% by the end of the week.

Brexit continues

The latest goings on with Brexit is causing a lot of confusion for the rest of the world, particularly in Europe.

There aren’t many ASX shares that have a large exposure to the UK. However, two that are exposed to the UK finished higher with a no-deal result seeming perhaps less likely. CYBG Plc (ASX: CYB) shares rose 5.2% over the week and Ramsay Health Care Limited (ASX: RHC) shares went up 3%.

Golden opportunity for Newcrest Mining Limited (ASX: NCM)?

Newcrest has entered into an exploration farm-in agreement that creates a joint venture with Greatland Gold plc on the Havieron tenement, located in WA. Newcrest will be the manager of the exploration program.

Newcrest is a decent idea as a hedge against markets falling in value, but over the long-term I think it’s better to buy ASX growth shares like these.

Top 3 Blue Chips To Buy For 2019

For many, blue chip stocks mean stability, profitability and regular dividends, often fully franked...

But knowing which blue chips to buy, and when, can be fraught with danger.

The Motley Fool’s in-house analyst team has poured over thousands of hours worth of proprietary research to bring you the names of "The Motley Fool’s Top 3 Blue Chip Stocks for 2019."

Each one pays a fully franked dividend. The names of these Top 3 ASX Blue Chips are included in this specially prepared free report. But you will have to hurry. Depending on demand – and how quickly the share prices of these companies move – we may be forced to remove this report.

Click here to claim your free report.

Motley Fool contributor Tristan Harrison has no position in any of the stocks mentioned. The Motley Fool Australia has recommended Kogan.com ltd and Ramsay Health Care Limited. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

One ASX Stock For An Estimated $US22 Billion Marijuana Market

A little-known ASX company just unlocked what some experts think could be the key to profiting off the coming marijuana boom.

And make no mistake – it is coming. To the tune of an estimated $US22 billion.

Cannabis legalisation is sweeping over North America, and full legalisation arrived in Canada in October 2018.

Here’s the best part: we think there’s one ASX stock that’s uniquely positioned to profit immensely from this explosive new industry… taking savvy investors along for what could be one heck of a ride.

AND, this is the first time The Motley Fool Australia has EVER put a BUY recommendation on a marijuana stock.

Simply click below to learn more on how you can profit from the coming cannabis boom.

Click here to find out more